StreetInsider.com News Articles

Form 6-K MindWalk Holdings Corp. For: Sep 22

Mon, 22 Sep 2025 09:51:00 -0400

si-local-file:///var/storage/secattach/20250922/25359274.html

Form 6-K MindWalk Holdings Corp. For: Sep 22

Mon, 22 Sep 2025 09:51:00 -0400

si-local-file:///var/storage/secattach/20250922/25359274.html

Form 6-K MindWalk Holdings Corp. For: Sep 15

Mon, 15 Sep 2025 08:52:00 -0400

si-local-file:///var/storage/secattach/20250915/25332968.html

Form 6-K MindWalk Holdings Corp. For: Sep 15

Mon, 15 Sep 2025 08:52:00 -0400

si-local-file:///var/storage/secattach/20250915/25332968.html

Form 6-K MindWalk Holdings Corp. For: Jul 31

Mon, 15 Sep 2025 08:51:00 -0400

si-local-file:///var/storage/secattach/20250915/25332966.html

Form 6-K MindWalk Holdings Corp. For: Jul 31

Mon, 15 Sep 2025 08:51:00 -0400

si-local-file:///var/storage/secattach/20250915/25332966.html

Form 6-K MindWalk Holdings Corp. For: Sep 10

Wed, 10 Sep 2025 09:42:00 -0400

si-local-file:///var/storage/secattach/20250910/25318861.html

Form 6-K MindWalk Holdings Corp. For: Sep 10

Wed, 10 Sep 2025 09:42:00 -0400

si-local-file:///var/storage/secattach/20250910/25318861.html

MindWalk to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2026 on September 15, 2025

Wed, 10 Sep 2025 08:16:00 -0400

The Company to host an earnings conference call via webcast

AUSTIN, Texas--(BUSINESS WIRE)-- MindWalk (NASDAQ: HYFT) (“HYFT” or the “Company”), a bio-native AI company operating at the intersection of TechBio and next-generation drug discovery, today announced that it will host a conference call to discuss its quarterly results and recent business highlights for first quarter fiscal year end 2026, on Monday, September 15, 2025, at 10:30 am Eastern Time. The financial results will be issued in a press release prior to the call. MindWalk management will host the conference call followed by a question-and-answer period.

Conference Call and

MindWalk to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2026 on September 15, 2025

Wed, 10 Sep 2025 08:16:00 -0400

The Company to host an earnings conference call via webcast

AUSTIN, Texas--(BUSINESS WIRE)-- MindWalk (NASDAQ: HYFT) (“HYFT” or the “Company”), a bio-native AI company operating at the intersection of TechBio and next-generation drug discovery, today announced that it will host a conference call to discuss its quarterly results and recent business highlights for first quarter fiscal year end 2026, on Monday, September 15, 2025, at 10:30 am Eastern Time. The financial results will be issued in a press release prior to the call. MindWalk management will host the conference call followed by a question-and-answer period.
Conference Call and

MindWalk to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2026 on September 15, 2025

Wed, 10 Sep 2025 08:16:00 -0400

The Company to host an earnings conference call via webcast

AUSTIN, Texas--(BUSINESS WIRE)-- MindWalk (NASDAQ: HYFT) (“HYFT” or the “Company”), a bio-native AI company operating at the intersection of TechBio and next-generation drug discovery, today announced that it will host a conference call to discuss its quarterly results and recent business highlights for first quarter fiscal year end 2026, on Monday, September 15, 2025, at 10:30 am Eastern Time. The financial results will be issued in a press release prior to the call. MindWalk management will host the conference call followed by a question-and-answer period.
Conference Call and

MindWalk to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2026 on September 15, 2025

Wed, 10 Sep 2025 08:16:00 -0400

The Company to host an earnings conference call via webcast

AUSTIN, Texas--(BUSINESS WIRE)-- MindWalk (NASDAQ: HYFT) (“HYFT” or the “Company”), a bio-native AI company operating at the intersection of TechBio and next-generation drug discovery, today announced that it will host a conference call to discuss its quarterly results and recent business highlights for first quarter fiscal year end 2026, on Monday, September 15, 2025, at 10:30 am Eastern Time. The financial results will be issued in a press release prior to the call. MindWalk management will host the conference call followed by a question-and-answer period.
Conference Call and

MindWalk to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2026 on September 15, 2025

Wed, 10 Sep 2025 08:16:00 -0400

The Company to host an earnings conference call via webcast

AUSTIN, Texas--(BUSINESS WIRE)-- MindWalk (NASDAQ: HYFT) (“HYFT” or the “Company”), a bio-native AI company operating at the intersection of TechBio and next-generation drug discovery, today announced that it will host a conference call to discuss its quarterly results and recent business highlights for first quarter fiscal year end 2026, on Monday, September 15, 2025, at 10:30 am Eastern Time. The financial results will be issued in a press release prior to the call. MindWalk management will host the conference call followed by a question-and-answer period.
Conference Call and

MindWalk to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2026 on September 15, 2025

Wed, 10 Sep 2025 08:16:00 -0400

The Company to host an earnings conference call via webcast

AUSTIN, Texas--(BUSINESS WIRE)-- MindWalk (NASDAQ: HYFT) (“HYFT” or the “Company”), a bio-native AI company operating at the intersection of TechBio and next-generation drug discovery, today announced that it will host a conference call to discuss its quarterly results and recent business highlights for first quarter fiscal year end 2026, on Monday, September 15, 2025, at 10:30 am Eastern Time. The financial results will be issued in a press release prior to the call. MindWalk management will host the conference call followed by a question-and-answer period.
Conference Call and

Form 6-K ImmunoPrecise Antibodies For: Sep 03

Wed, 03 Sep 2025 09:21:00 -0400
si-local-file:///var/storage/secattach/20250903/25289640.html

Form 6-K ImmunoPrecise Antibodies For: Sep 03

Wed, 03 Sep 2025 09:21:00 -0400
si-local-file:///var/storage/secattach/20250903/25289640.html

ImmunoPrecise rebrands as MindWalk, changes ticker to HYFT

Wed, 03 Sep 2025 08:48:59 -0400

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) announced it has rebranded as MindWalk and will change its NASDAQ ticker symbol to HYFT. The company said the rebrand unifies ImmunoPrecise with its subsidiaries BioStrand and Talem under a single corporate brand.
The Austin, Texas-based company operates what it describes as a Bio-Native AI platform that combines artificial intelligence, multi-omics data, and laboratory research. The company's technology platform includes LensAI powered by HYFT technology for biologics discovery and development.
"Today is an evolutionary step forward," said Dr. Jennifer Bath, president and chief executive officer of MindWalk. "Inspired by Darwin's thinking path, MindWalk is about seeing what

ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT”

Wed, 03 Sep 2025 08:48:00 -0400

An Evolution in Name, Structure, and Strategy Reflecting the Company’s AI-Driven Platform and Bio-Native Discovery Vision

AUSTIN, Texas--(BUSINESS WIRE)-- ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), ImmunoPrecise Antibodies Ltd. and its subsidiaries (BioStrand and Talem) today announced a unification under a single corporate brand, MindWalk, and a change of its Nasdaq ticker symbol to HYFT. The new identity conveys the Company’s evolution into a Bio-Native AI platform business built at the intersection of AI, multi-omics data, and advanced laboratory research.
“Today is an evolutionary step forward,” said Dr. Jennifer Bath, President and Chief Executive Officer of

ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT”

Wed, 03 Sep 2025 08:48:00 -0400

An Evolution in Name, Structure, and Strategy Reflecting the Company’s AI-Driven Platform and Bio-Native Discovery Vision

AUSTIN, Texas--(BUSINESS WIRE)-- ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), ImmunoPrecise Antibodies Ltd. and its subsidiaries (BioStrand and Talem) today announced a unification under a single corporate brand, MindWalk, and a change of its Nasdaq ticker symbol to HYFT. The new identity conveys the Company’s evolution into a Bio-Native AI platform business built at the intersection of AI, multi-omics data, and advanced laboratory research.
“Today is an evolutionary step forward,” said Dr. Jennifer Bath, President and Chief Executive Officer of

ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT”

Wed, 03 Sep 2025 08:48:00 -0400

An Evolution in Name, Structure, and Strategy Reflecting the Company’s AI-Driven Platform and Bio-Native Discovery Vision

AUSTIN, Texas--(BUSINESS WIRE)-- ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), ImmunoPrecise Antibodies Ltd. and its subsidiaries (BioStrand and Talem) today announced a unification under a single corporate brand, MindWalk, and a change of its Nasdaq ticker symbol to HYFT. The new identity conveys the Company’s evolution into a Bio-Native AI platform business built at the intersection of AI, multi-omics data, and advanced laboratory research.
“Today is an evolutionary step forward,” said Dr. Jennifer Bath, President and Chief Executive Officer of

ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT”

Wed, 03 Sep 2025 08:48:00 -0400

An Evolution in Name, Structure, and Strategy Reflecting the Company’s AI-Driven Platform and Bio-Native Discovery Vision

AUSTIN, Texas--(BUSINESS WIRE)-- ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), ImmunoPrecise Antibodies Ltd. and its subsidiaries (BioStrand and Talem) today announced a unification under a single corporate brand, MindWalk, and a change of its Nasdaq ticker symbol to HYFT. The new identity conveys the Company’s evolution into a Bio-Native AI platform business built at the intersection of AI, multi-omics data, and advanced laboratory research.
“Today is an evolutionary step forward,” said Dr. Jennifer Bath, President and Chief Executive Officer of

Form 6-K ImmunoPrecise Antibodies For: Sep 02

Tue, 02 Sep 2025 08:59:00 -0400
si-local-file:///var/storage/secattach/20250902/25282063.html

Form 6-K ImmunoPrecise Antibodies For: Sep 02

Tue, 02 Sep 2025 08:59:00 -0400
si-local-file:///var/storage/secattach/20250902/25282063.html

ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 27th Annual Global Investment Conference in New York

Tue, 02 Sep 2025 08:01:00 -0400

AUSTIN, Texas--(BUSINESS WIRE)-- ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), today announced that it will participate in the 27th Annual H.C. Wainwright Global Investment Conference, taking place September 8th through September 10th, 2025.
Dr. Jennifer Bath, President CEO of IPA, will deliver a company presentation and be available for one-on-one investor meetings throughout the event.
Event Details:

Conference: 27th Annual H.C. Wainwright Global Investment Conference

Date: September 8-10th, 2025

Investors interested in scheduling a meeting with the IPA management team should contact their H.C. Wainwright representative or email meetings@hcwco.com
About ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd.

ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 27th Annual Global Investment Conference in New York

Tue, 02 Sep 2025 08:01:00 -0400

AUSTIN, Texas--(BUSINESS WIRE)-- ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), today announced that it will participate in the 27th Annual H.C. Wainwright Global Investment Conference, taking place September 8th through September 10th, 2025.
Dr. Jennifer Bath, President CEO of IPA, will deliver a company presentation and be available for one-on-one investor meetings throughout the event.
Event Details:

Conference: 27th Annual H.C. Wainwright Global Investment Conference

Date: September 8-10th, 2025

Investors interested in scheduling a meeting with the IPA management team should contact their H.C. Wainwright representative or email meetings@hcwco.com
About ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd.